Agilent Beats Q3 Estimates with 8.1% Revenue Growth Driven by Core Demand

Key Facts

1Agilent reported Q3 revenue of $1.88 billion, an 8.1% increase year-over-year.

2Non-GAAP net income reached $459 million, with GAAP earnings per share at $1.28.

Reflecting a steady performance within the healthcare sector, Agilent Technologies has reported financial results that underscore robust demand in its core markets. According to reports, the company achieved revenue of $1.88 billion in its fiscal third quarter of 2026, marking an 8.1% increase compared to the previous year. This growth was primarily propelled by a 7.3% rise in core revenue, highlighting sustained momentum in its analytical laboratory and diagnostics segments.

Regarding profitability, the financial data reveals that non-GAAP net income reached $459 million, while GAAP earnings per share stood at $1.28. This performance represents an increase in net income relative to the prior year, aligning with the typical trajectory of a stable large-cap company delivering an earnings beat within the diagnostics and healthcare industry.

In the equity markets, the ticker A closed at $152.955 (as of August 26, 2026), having reached a session high of $154.84. As there are no immediate sector-specific catalysts in the upcoming economic calendar, investors will likely focus on whether the company can maintain this demand trajectory, noting that the stock found intraday support near $152.895.